NFA
PTLA

Nationwide Fund Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Nationwide Fund Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-62,176
Closed -$3.36M – 2672
2017
Q3 		$3.36M Buy
62,176
+10,526
+20% +$618K 0.01% 1201
2017
Q2 		$2.9M Buy
51,650
+8,587
+20% +$344K 0.01% 1270
2017
Q1 		$1.69M Sell
43,063
-2,135
-5% -$68K 0.01% 1484
2016
Q4 		$1.01M Sell
45,198
-1,721
-4% -$33.6K ﹤0.01% 1774
2016
Q3 		$1.07M Hold
46,919
– – ﹤0.01% 1747
2016
Q2 		$1.11M Sell
46,919
-54
-0.1% -$1.33K ﹤0.01% 1676
2016
Q1 		$974K Buy
46,973
+83
+0.2% +$2.63K ﹤0.01% 1739
2015
Q4 		$2.41M Buy
46,890
+2,590
+6% +$126K 0.01% 1278
2015
Q3 		$1.89M Sell
44,300
-692
-2% -$33.4K 0.01% 1397
2015
Q2 		$2.05M Sell
44,992
-8,122
-15% -$327K 0.01% 1410
2015
Q1 		$2.02M Buy
53,114
+3,780
+8% +$130K 0.01% 1471
2014
Q4 		$1.4M Buy
49,334
+4,189
+9% +$116K 0.01% 1621
2014
Q3 		$1.14M Buy
45,145
+21
+0% +$553 ﹤0.01% 1760
2014
Q2 		$1.32M Buy
45,124
+19,799
+78% +$479K 0.01% 1716
2014
Q1 		$656K Buy
25,325
+2,090
+9% +$55.8K ﹤0.01% 1930
2013
Q4 		$598K Buy
23,235
+15,538
+202% +$378K ﹤0.01% 2159
2013
Q3 		$206K Buy
7,697
+4,598
+148% +$109K ﹤0.01% 2642
2013
Q2 		$76K Buy
+3,099
New +$61.6K ﹤0.01% 2878

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Nationwide Fund Advisors's PTLA Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2017, closing a stake of 62,176 shares — an estimated $3.36M sold.

Nationwide Fund Advisors first reported a position in PTLA in Q2 2013 and held it in 18 quarters. The position peaked at $3.36M in Q3 2017. 215 funds tracked by Wall St. Rank hold PTLA as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 62,176 Portola Pharmaceuticals, Inc. shares in Q4 2017, an estimated $3.36M.
  • Nationwide Fund Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Portola Pharmaceuticals, Inc. position peaked at $3.36M in Q3 2017.
  • 215 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.